These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8907302)

  • 1. Effects of pluronic F-68 (poloxamer 188) on platelet aggregation in human whole blood.
    Edwards CM; May JA; Heptinstall S; Lowe KC
    Thromb Res; 1996 Feb; 81(4):511-2. PubMed ID: 8907302
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of the co-polymer surfactant, Pluronic F-68, on platelet aggregation in human whole blood.
    Edwards CM; Heptinstall S; Lowe KC
    Artif Cells Blood Substit Immobil Biotechnol; 1997 Sep; 25(5):493-9. PubMed ID: 9285052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of red blood cell-induced platelet aggregation in whole blood by a nonionic surfactant, poloxamer 188 (RheothRx injection).
    Armstrong JK; Meiselman HJ; Fisher TC
    Thromb Res; 1995 Sep; 79(5-6):437-50. PubMed ID: 7502270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel fluoro-surfactants for perfluorochemical emulsification. Effects on aggregation of human platelets in vitro and possible applications as anti-thrombotic agents.
    Edwards CM; Lowe KC; Heptinstall S; Lucas P; Trabelsi H; Cambon A
    Adv Exp Med Biol; 1997; 428():489-93. PubMed ID: 9500089
    [No Abstract]   [Full Text] [Related]  

  • 5. Pluronic F-68 inhibits agonist-induced platelet aggregation in human whole blood in vitro.
    Edwards CM; Heptinstall S; Lowe KC
    Artif Cells Blood Substit Immobil Biotechnol; 1998 Nov; 26(5-6):441-7. PubMed ID: 9844710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Poloxamer 188 on fibrin network structure, whole blood clot premeability and fibrinolysis.
    van Gelder JM; Nair CH; Dhall DP
    Thromb Res; 1993 Sep; 71(5):361-76. PubMed ID: 8236163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro inhibition of aggregation of human erythrocytes by synthetic fibrinolytic compounds.
    von Kaulla KN
    Arzneimittelforschung; 1975 Feb; 25(2):152-5. PubMed ID: 1173027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of different anticoagulants on platelet aggregation in whole blood; a comparison between citrate, low molecular mass heparin and hirudin.
    Wallén NH; Ladjevardi M; Albert J; Bröijersén A
    Thromb Res; 1997 Jul; 87(1):151-7. PubMed ID: 9253810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effects of total flavones of Hippophae Rhamnoides L on thrombosis in mouse femoral artery and in vitro platelet aggregation.
    Cheng J; Kondo K; Suzuki Y; Ikeda Y; Meng X; Umemura K
    Life Sci; 2003 Apr; 72(20):2263-71. PubMed ID: 12628446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of the effects of three positive inotropic agents (amrinone, milrinone and medorinone) on platelet aggregation in human whole blood.
    Pattison A; Astley N; Eason CT; Bonner FW
    Thromb Res; 1990 Mar; 57(6):909-18. PubMed ID: 2116683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Platelet hyperaggregability secondary to thrombolytic treatment].
    Brochier M; Griguer P
    Acta Clin Belg; 1975; 30(3):210-20. PubMed ID: 1231460
    [No Abstract]   [Full Text] [Related]  

  • 12. The glycoprotein IIb/IIIa platelet receptor blocker tirofiban, but not heparin, counteracts platelet aggregation in unstable angina pectoris.
    Mattsson E; Martinsson A; Nyqvist O; Rasmanis G; Sylvén C; Karlberg KE
    Am J Cardiol; 1997 Oct; 80(7):938-40. PubMed ID: 9382012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antagonism of the GPIIb/IIIa receptor with the nonpeptidic molecule BIBU52: inhibition of platelet aggregation in vitro and antithrombotic efficacy in vivo.
    Guth BD; Seewaldt-Becker E; Himmelsbach F; Weisenberger H; Müller TH
    J Cardiovasc Pharmacol; 1997 Aug; 30(2):261-72. PubMed ID: 9269956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of arterial thrombosis and platelet function by nafazatrom.
    Buchanan MR; Blajchman M; Hirsh J
    Thromb Res; 1982 Oct; 28(2):157-70. PubMed ID: 6758186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of methylflavonolamine on platelet aggregation in rabbits].
    Wu YJ; Zhou EF; Hao YB
    Zhongguo Yao Li Xue Bao; 1988 Jan; 9(1):79-83. PubMed ID: 3188941
    [No Abstract]   [Full Text] [Related]  

  • 16. Suloctidil: a novel inhibitor of platelet aggregation in human beings.
    de Gaetano G; Miragliotta G; Roncucci R; Lansen J; Lambelin G
    Thromb Res; 1976 Mar; 8(3):361-71. PubMed ID: 1265708
    [No Abstract]   [Full Text] [Related]  

  • 17. [Combined effects of PGI2 and thrombin inhibitors or fibrinolytic agent on platelet aggregation and disaggregation].
    Takahashi H; Nagayama R; Fuse I; Hattori A; Shibata A
    Rinsho Ketsueki; 1984 Jul; 25(7):998-1003. PubMed ID: 6389931
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of the effects of streptokinase, t-PA and APSAC on human platelet aggregation in vitro in the absence and presence of aspirin.
    Fears R; Ferres H; Greenwood HC
    Thromb Res; 1990 Nov; 60(4):259-68. PubMed ID: 2128420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on new antiplatelet agents, WS-30581 A and B.
    Umehara K; Yoshida K; Okamoto M; Iwami M; Tanaka H; Kohsaka M; Imanaka H
    J Antibiot (Tokyo); 1984 Oct; 37(10):1153-60. PubMed ID: 6501088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Inhibitory effect of 2-acetoxy-4-trifluoromethylbenzoic acid (triflusal) and aspirin on platelet aggregation in man and rat: in vitro study].
    Garcia-Rafanell J; Morell J
    Therapie; 1977; 32(3):337-44. PubMed ID: 929503
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.